Suppr超能文献

赖布尔市药品不良反应监测中心的药品不良反应:1年期间自发报告分析

Adverse drug reactions at adverse drug reaction monitoring center in Raipur: Analysis of spontaneous reports during 1 year.

作者信息

Singh Preeti, Agrawal Manju, Hishikar Rajesh, Joshi Usha, Maheshwari Basant, Halwai Ajay

机构信息

Department of Pharmacology, ADR Monitoring Centre (PvPI, Ministry of Health and Family Welfare, GoI), Pt. J.N.M. Medical College, Raipur, India.

Department of Pharmacology, Pt. J.N.M. Medical College, Raipur, Chhattisgarh, India.

出版信息

Indian J Pharmacol. 2017 Nov-Dec;49(6):432-437. doi: 10.4103/ijp.IJP_781_16.

Abstract

BACKGROUND

India is a developing country and adverse drug reactions (ADRs) influence most of the diseases in our population, and monitoring is required due to the paucity of ADRs. The present study was done to analyze the ADRs at the ADR monitoring center (AMC) of tertiary care hospital in Raipur during 1 year.

MATERIALS AND METHODS

Study of ADR monitoring of outpatient and inpatient was a prospective and observational study carried out between September 2015 and August 2016. The ADRs in the form of Individual Case Safety Report (ICSR) was sent to the Indian database (Vigiflow).

RESULTS

Total ICSRs reported to Vigiflow were 232 during 1 year. Among them, 63.79% were found to be nonserious and 36.21% were serious. Nearly 45% of ADRs were implicated only due to antimicrobials, which is highest among all other groups of drugs. A maximum number of ADRs were observed in 31-60 years of age group (52.15%). In causality assessment, the probable cases had a higher incidence (67.24%), followed by possible (27.58%) and certain (4.74%). The frequency of ADR reporting at our AMC was low (0.043%) compared to national average. Our AMC shared 0.35% of total ICSRs, which is insignificant ( < 0.001) compared to the JSS, Mysore and PGIMER, Chandigarh, AMCs, which have shared most of the ICSRs in Vigiflow.

CONCLUSIONS

The frequencies of ADRs reporting in our study are less compared to those reported with other similar studies. Underreporting is a very serious concern in Raipur, and Pharmacovigilance Programme of India must intercede to pick up ADRs across the country.

摘要

背景

印度是一个发展中国家,药物不良反应(ADR)影响着我国大多数人口所患的疾病,由于ADR报告数量匮乏,因此需要进行监测。本研究旨在分析赖布尔一家三级护理医院的ADR监测中心(AMC)在1年期间的ADR情况。

材料与方法

对门诊和住院患者的ADR监测研究是一项前瞻性观察性研究,于2015年9月至2016年8月进行。以个体病例安全报告(ICSR)形式的ADR被发送至印度数据库(Vigiflow)。

结果

1年期间向Vigiflow报告的ICSR总数为232份。其中,63.79%被认定为非严重ADR,36.21%为严重ADR。近45%的ADR仅与抗菌药物有关,这在所有其他药物类别中占比最高。在31 - 60岁年龄组中观察到的ADR数量最多(52.15%)。在因果关系评估中,很可能的病例发生率较高(67.24%),其次是可能的(27.58%)和肯定的(4.74%)。与全国平均水平相比,我们AMC的ADR报告频率较低(0.043%)。我们的AMC占ICSR总数的0.35%,与迈索尔的JSS和昌迪加尔的PGIMER的AMC相比微不足道(<0.001),后者在Vigiflow中分享了大部分ICSR。

结论

与其他类似研究报告的情况相比,我们研究中的ADR报告频率较低。在赖布尔,漏报是一个非常严重的问题,印度药物警戒计划必须进行干预以收集全国范围内的ADR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d74b/5892024/f1f2fabddfa2/IJPharm-49-432-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验